Our science Our goal is to fundamentally change the way people think about cancer treatment by pushing the boundaries of what is possible with cell therapy — using genetically modified immune cells to target tumors. Our engineered cell therapies express either a chimeric antigen receptor (CAR) or a T cell receptor (TCR), depending on the type of cancer. This dual platform has the potenti...
kitepharma.com was registered 1 decade 5 years ago. It has a alexa rank of #814,057 in the world. It is a domain having .com extension. It is estimated worth of $ 1,680.00 and have a daily income of around $ 7.00. As no active threats were reported recently, kitepharma.com is SAFE to browse.
Daily Unique Visitors: | 1,077 |
Daily Pageviews: | 2,154 |
Income Per Day: | $ 7.00 |
Estimated Worth: | $ 1,680.00 |
Google Indexed Pages: | Not Applicable |
Yahoo Indexed Pages: | Not Applicable |
Bing Indexed Pages: | Not Applicable |
Google Backlinks: | Not Applicable |
Bing Backlinks: | Not Applicable |
Alexa BackLinks: | Not Applicable |
Google Safe Browsing: | No Risk Issues |
Siteadvisor Rating: | Not Applicable |
WOT Trustworthiness: | Very Poor |
WOT Privacy: | Very Poor |
WOT Child Safety: | Very Poor |
Alexa Rank: | 814,057 |
PageSpeed Score: | 89 ON 100 |
Domain Authority: | 49 ON 100 |
Bounce Rate: | Not Applicable |
Time On Site: | Not Applicable |
Total Traffic: | No Data |
Direct Traffic: | No Data |
Referral Traffic: | No Data |
Search Traffic: | No Data |
Social Traffic: | No Data |
Mail Traffic: | No Data |
Display Traffic: | No Data |
Kite Pharma has tapped immunotherapy expert Francesco Marincola, a former National Institutes of Health investigator, to helm the company's cell therapy ...
The latest Tweets from Kite, a Gilead Company (@KitePharma). Our singular focus is #celltherapy, which we believe has the ability to change the way #cancer is ...
Kite, a Gilead Company, Santa Monica, CA, USA. [email protected]. PMID: 30196500; DOI: 10.1007/978-1 ...
Discovery. Every day. Be at the edge of change. Today, Kite is the leader in cell therapy. We are advancing a pipeline of oncology therapies centered on what ...
Contact and general information about Kite Pharma company, headquarter location in Santa Monica, California. Email formats & phone numbers of Kite Pharma ...
Kite Pharma. Location. PO Box 25270. San Mateo, California 94402-5270. United States. Contact Info. (310) 824-9999 · https://www.kitepharma.com/.
Information on acquisition, funding, cap tables, investors, and executives for Kite Pharma. Use the PitchBook Platform to explore the full profile.
Kite Pharma Inc ... Kite Pharma, Inc. develops and manufacturers pharmaceuticals. The Company offers and designs cancer immunotherapeutic products and ...
Kite Pharma. www.kitepharma.com. 2225 Colorado Avenue Santa Monica CA 90404. United States +1 310 824 9999. Activities. Pharmaceuticals. Related ...
If you're looking to find emails of Kite Pharma employees then you've come to the right place. Whether you're looking to discover the company email format for ...
Therapies icon Our Therapies ... Kite has been at the forefront of cancer immunotherapy since 2009. Today, we are a leader in engineered T cell therapy, which has ...
Kite Pharma, immune-based therapies to treat cancer indications. Here you'll find information about their funding, investors and team.
Kite Pharma, Inc. 2225 Colorado Avenue Santa Monica, 90404 US. Tel: (844) 454-KITE. http://https://www.kitepharma.com ...
Kite Pharma, founded in 2009, is a clinical-stage biopharmaceutical company focused on the development & commercialization of novel cancer immunotherapy ...
Kite Pharma, Inc. 2225 Colorado Avenue Santa Monica, 90404 US. Tel: (844) 454-KITE. http://https://www.kitepharma.com ...
KITE PHARMA INC (GILEAD). Kite Pharma. Category:Manufacturing, Fortune 500, Bioscience; Address:2355 UTAH AVE EL SEGUNDO, CA 90245 ...
Kite Pharma, Inc. 2225 Colorado Avenue Santa Monica, CA 90404 US. Tel: (844) 454-KITE. http://https://www.kitepharma.com ...
For Current Kite Pharma Employees and Contractors: ... and make a substantial contribution to our treatment and the growth and development of Kite Pharma.
1-310-496-0397 or email at [email protected]. □ Report any ... are trademarks of Kite Pharma, Inc. GILEAD is a trademark of Gilead Sciences, Inc.
Dec 31, 2020 ... Kite Pharma Overview ... Kite Pharma, a subsidiary of Gilead Sciences, develops cancer immunotherapy products with a primary focus on ...
Kite Pharma is a developmentstage biotechnology company designing and developing immunebased therapies to treat cancer indications. icon ...
Kite Pharma. kitepharma.com. Industry. Biotechnology. Employees. 201-500. Location. Not available. Email Formats. Format. Chance. {f}{last}@kitepharma. com.
H1 Headings: | 1 | H2 Headings: | 5 |
H3 Headings: | Not Applicable | H4 Headings: | Not Applicable |
H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
Total IFRAMEs: | 1 | Total Images: | 16 |
Google Adsense: | Not Applicable | Google Analytics: | Not Applicable |
Words | Occurrences | Density | Possible Spam |
---|---|---|---|
cell therapy | 4 | 0.922 % | No |
Our Mission | 3 | 0.691 % | No |
at Kite | 3 | 0.691 % | No |
cancer treatment | 3 | 0.691 % | No |
Contact Us | 3 | 0.691 % | No |
Mission Our | 3 | 0.691 % | No |
of cancer | 3 | 0.691 % | No |
Our Therapies | 3 | 0.691 % | No |
MAIN MENU | 2 | 0.461 % | No |
TO MAIN | 2 | 0.461 % | No |
BACK TO | 2 | 0.461 % | No |
Careers at | 2 | 0.461 % | No |
on the | 2 | 0.461 % | No |
Company Statements | 2 | 0.461 % | No |
See Our | 2 | 0.461 % | No |
boundaries of | 2 | 0.461 % | No |
T cell | 2 | 0.461 % | No |
solid tumors | 2 | 0.461 % | No |
Pipeline Our | 2 | 0.461 % | No |
the boundaries | 2 | 0.461 % | No |
Words | Occurrences | Density | Possible Spam |
---|---|---|---|
BACK TO MAIN MENU | 2 | 0.461 % | No |
pushing the boundaries of | 2 | 0.461 % | No |
breakthroughs in medicine since | 1 | 0.23 % | No |
biggest breakthroughs in medicine | 1 | 0.23 % | No |
the biggest breakthroughs in | 1 | 0.23 % | No |
in medicine since the | 1 | 0.23 % | No |
of the biggest breakthroughs | 1 | 0.23 % | No |
medicine since the introduction | 1 | 0.23 % | No |
of combination chemotherapy more | 1 | 0.23 % | No |
introduction of combination chemotherapy | 1 | 0.23 % | No |
the introduction of combination | 1 | 0.23 % | No |
since the introduction of | 1 | 0.23 % | No |
one of the biggest | 1 | 0.23 % | No |
as one of the | 1 | 0.23 % | No |
therapy which has changed | 1 | 0.23 % | No |
which has changed the | 1 | 0.23 % | No |
cell therapy which has | 1 | 0.23 % | No |
T cell therapy which | 1 | 0.23 % | No |
engineered T cell therapy | 1 | 0.23 % | No |
has changed the paradigm | 1 | 0.23 % | No |
Learn about BIKTARVY® (bictegravir, emtricitabine, and tenofovir alafenamide), and ask your doctor if BIKTARVY® is right for you. Read benefits & risks.
Zelis® Payments is a leading healthcare payments technology company dedicated to delivering value via exceptional client experiences.
Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.
Domain Registrar: | CSC Corporate Domains, Inc. |
---|---|
Registration Date: | 2009-06-12 1 decade 5 years 5 months ago |
Last Modified: | 2020-12-30 3 years 10 months 2 weeks ago |
Host | IP Address | Country | |
---|---|---|---|
dns1.cscdns.net | 156.154.130.100 | United States | |
dns2.cscdns.net | 156.154.131.100 | United States |
Host | Type | TTL | Extra |
---|---|---|---|
kitepharma.com | A | 3596 |
IP: 40.70.27.35 |
kitepharma.com | NS | 3600 |
Target: dns2.cscdns.net |
kitepharma.com | NS | 3600 |
Target: dns1.cscdns.net |
kitepharma.com | SOA | 3600 |
MNAME: dns1.cscdns.net RNAME: hostmaster.cscdns.net Serial: 2020111805 Refresh: 28800 Retry: 7200 Expire: 604800 |
kitepharma.com | MX | 600 |
Priority: 5 Target: ppa |
kitepharma.com | MX | 600 |
Priority: 5 Target: ppb |
kitepharma.com | MX | 600 |
Priority: 10 Target: mxa-002ff601.gslb.pphosted.com |
kitepharma.com | MX | 600 |
Priority: 10 Target: mxb-002ff601.gslb.pphosted.com |
kitepharma.com | TXT | 3600 |
TXT: adobe-idp-site-verification=adb0a46c-638 4-465a-a098-6203733b378e |
kitepharma.com | TXT | 3600 |
TXT: apple-domain-verification=Z8iIDlzVzz3ePH 3F |
kitepharma.com | TXT | 3600 |
TXT: cwsauthsprod-wr.azurewebsites.net |
kitepharma.com | TXT | 3600 |
TXT: docusign=1554ba3e-716d-4206-aa53-62b7bec 37aa4 |
kitepharma.com | TXT | 3600 |
TXT: docusign=6059c332-6aec-49ef-9ef7-5702ad1 66c1c |
kitepharma.com | TXT | 3600 |
TXT: v=spf1 include:spf.protection.outlook.com include:spf-002ff601.pphosted.com -all |
kitepharma.com | TXT | 3600 |
TXT: CFVERIFY346790 |
kitepharma.com | TXT | 600 |
TXT: MS=ms39432607 |
kitepharma.com | TXT | 600 |
TXT: MS=ms80836664 |
Все о зрении и здоровье глаз, о болезнях, диагностике и лечении
Comunitatea Creativa din Romania - Platforma online ce le permite creatorilor romani sa se conecteze intre ei si cu cei care le apreciaza munca.
Comment choisir sa literie et le bon modèle de matelas ? Guide Literie vous accompagne. Garnissage, aération, indépendance de couchage, fermeté, matelas latex ou ressorts,...